Dermatology Drugs Market, (By Disease Type: Acne, Allergic Dermatology, Rashes, Dermatitis, Actinic Keratosis. By Distribution: Hypermarket or Supermarket, Online Market, Pharmaceutical Stores .By End-User: Hospitals, Skincare Clinics, Dermatology Clinics. By Product: Ointments, Antibiotics, Laser Therapy, Antihistamines. By Region - North America, Europe, Asia Pacific, and LAMEA) – Global Industry Insights, Analysis, Trends, and Forecast 2022-2032

The global dermatology drugs market was valued at $21.2 billion in 2021 and it is expected to reach $72.4 billion at a CAGR of 11.60% between 2022 and 2032. Dermatology is a kind of medicine that is used to deal with skin diseases. These medicines further cure diseases related to nail, hair, scalp, and cosmetic problems. Dermatology involves the study and research, management, and diagnosis of any kind of health condition that may affect the skin, fat hair, nails, and membrane, among others.

By region, North America is leading the dermatology drugs market across the globe.   

Based on diseases, the dermatology drugs market is segmented into acne, allergic dermatology, rashes, dermatitis, actinic keratosis, psoriasis, and more. Among these, acne and psoriasis are the major diseases that are driving the growth of the market. Based on the distributional channel, the market is categorized into hypermarkets or supermarkets, online stores, and pharmaceutical stores. Among these categories, the pharmaceutical and online retail segment is leading the distributional channel and supporting the global dermatology drugs market to grow across various nations. Based on the end-user, the dermatology drugs market is segmented into hospitals, skincare clinics, dermatology clinics, and others. Among these categories, the skincare clinic is expected to dominate the dermatology drugs market over the forecast period.

Source: SAI Research

Download Free PDF Sample

Based on product type, the market is categorized into ointments, antibiotics, laser therapy, antihistamines, and others. Furthermore, based on the region, the dermatology drugs market is segmented into North America, Europe, Asia-Pacific, Latin America, Africa, and the Middle East region. Among these regions, North America is the leading market across the globe followed by the Middle East and Asia-Pacific regions. Skin diseases are increasing among the geriatric population and children in several developed countries such U.S, Canada, India, China, and Mexico, among others. Therefore, these major factors are expected to drive the growth of the global dermatology drugs market.  

The global dermatology drugs market is expected to witness a significant growth opportunity during the forecast period owing to some activities such as collaborations, mergers, acquisitions, partnerships, and new product launches across various regions. Over the past few years, a few key players such as LEO Pharmaceuticals Company and Merck Pharmaceutical Company strengthened their position in the global dermatology drugs market by developing new business strategies and producing new medicine products for providing treatment. Moreover, the growing awareness among the worldwide population is another factor that is driving the growth of the market. Additionally, skin-related disorders such as changes in the connective tissue, and reduction in the skin’s strength are rising in a few developing countries is one of the major factors driving the market growth over a couple of years.   

According to the study, key players such as are Bausch Health Pharmaceutical Company (Canada), Novartis Pharmaceutical Company (Switzerland), Pfizer Pharmaceutical Industry Company (U.S), Johnson and Johnson Pharmaceutical Company (U.S), Merck Pharmaceutical Company (U.S), Abbvie Company (U.S), Sanofi Pharmaceutical Industry Company (France), Amgen Biotechnology Company (U.S), AstraZeneca Pharmaceutical Industry Company (U.K), among others are leading the global dermatology drugs market.                    

Scope of the Report:

The Global Dermatology Drugs Market Has Been Segmented Into:

The Global Dermatology Drugs Market – By Disease Type: 

• Acne
• Allergic Dermatology
• Rashes
• Dermatitis
• Actinic Keratosis
• And Others

The Global Dermatology Drugs Market – By Distribution:

• Hypermarket or Supermarket
• Online Market
• Pharmaceutical Stores

The Global Dermatology Drugs Market – By End-User:

• Hospitals
• Skincare Clinics
• Dermatology Clinics
• And Others

The Global Dermatology Drugs Market – By Product:

• Ointments
• Antibiotics
• Laser Therapy
• Antihistamines

The Global Dermatology Drugs Market – By Regions:     

North America 

• U.S.
• Canada
• Mexico

Europe

• Germany
• France
• Italy
• U.K.
• Russia
• Rest of Europe Countries

Asia-Pacific

• India
• China
• Japan
• South Korea
• North Korea
• Rest of Asian Countries

LAMEA

• Brazil
• Saudi Arabia
• Rest of LAMEA